News Sentiment

7148 sentiment intelligence

Duopharma Biotech Berhad news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 4 relevant articles
Exchange KLS Malaysia
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 1.24 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

80/100 classification confidence.

Company focus 4

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+0.0% over one week, +0.0% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Duopharma Biotech Berhad (KLSE:DPHARMA) is a favorite amongst institutional investors who own 72%

Market Reaction

Balanced read

48/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 80/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend inactive 0.0% over four weeks
Fair value 2.2% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 4
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 4
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 1
BusinessToday Malaysia 1
The Edge Malaysia 1
aap.com.au 1

Event Lens

What the news is about

Classified themes
Market update 4

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-4 of 4